Literature DB >> 14994410

Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach.

Erika Rodrigues Senna1, Ana Letícia P De Barros, Edvânia O Silva, Isabella F Costa, Leonardo Victor B Pereira, Rozana Mesquita Ciconelli, Marcos Bosi Ferraz.   

Abstract

OBJECTIVE: To estimate the prevalence of rheumatic diseases in residents of Montes Claros, Brazil, of both sexes, aged above 16 years, using the COPCORD questionnaire.
METHODS: This was a cross-sectional study of 3038 people; the sample was probabilistic, by conglomerates, multiple stages, within homogeneous strata, the sampling unit being the domicile. The COPCORD questionnaire was used for all subjects, and a rheumatologist evaluated those patients who presented pain and/or functional disability. Laboratory tests and radiographs of small and large joints were done in some patients to confirm the diagnosis. Subjects were identified by socioeconomic level in quintiles A, B, C, D, and E, A being the highest.
RESULTS: Two hundred nineteen patients were identified with rheumatic diseases, mean age 37 (SD 27) years, with female predominance. Seventy-seven (35.2%) were unemployed and socioeconomic level D was the most prevalent. Of all patients with rheumatic disease, osteoarthritis (OA) was observed in 126 (57.5%) patients, fibromyalgia (FM) in 76 (34.7%), rheumatoid arthritis (RA) in 14 (6.4%), and lupus in 3 (1.4%). Women were predominant in all diseases except OA. The mean (SD) age was 56 (12.7) years for OA, 43.2 (9.1) for FM, 53.4 (13.9) for RA, and 40 (14) for lupus.
CONCLUSION: The prevalence of rheumatic diseases evaluated by the COPCORD questionnaire was 4.14% for OA, 2.5% for FM, 0.46% for RA, and 0.098% for lupus.

Entities:  

Mesh:

Year:  2004        PMID: 14994410

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  60 in total

Review 1.  Worldwide epidemiology of fibromyalgia.

Authors:  Luiz Paulo Queiroz
Journal:  Curr Pain Headache Rep       Date:  2013-08

2.  Culture-sensitive adaptation and validation of the community-oriented program for the control of rheumatic diseases methodology for rheumatic disease in Latin American indigenous populations.

Authors:  Ingris Peláez-Ballestas; Ysabel Granados; Adriana Silvestre; José Alvarez-Nemegyei; Evart Valls; Rosana Quintana; Yemina Figuera; Flor Julian Santiago; Mario Goñi; Rosa González; Natalia Santana; Romina Nieto; Irais Brito; Imelda García; Maria Cecilia Barrios; Manuel Marcano; Adalberto Loyola-Sánchez; Ivan Stekman; Marisa Jorfen; Maria Victoria Goycochea-Robles; Fadua Midauar; Rosa Chacón; Maria Celeste Martin; Bernardo A Pons-Estel
Journal:  Rheumatol Int       Date:  2014-03-29       Impact factor: 2.631

Review 3.  Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria.

Authors:  John McBeth; Matthew R Mulvey
Journal:  Nat Rev Rheumatol       Date:  2012-01-24       Impact factor: 20.543

4.  Effect of ethnic origin (Caucasians versus Turks) on the prevalence of rheumatic diseases: a WHO-ILAR COPCORD urban study in Iran.

Authors:  Fereydoun Davatchi; Ahmad-Reza Jamshidi; Arash Tehrani Banihashemi; Jaleh Gholami; Mohammad Hossein Forouzanfar; Massoomeh Akhlaghi; Mojgan Barghamdi; Elham Noorolahzadeh; Ali-Reza Khabazi; Mansour Salesi; Amir-Hossein Salari; Mansoor Karimifar; Kamal Essalat-Manesh; Mehrzad Hajialiloo; Mohsen Soroosh; Farhad Farzad; Hamid-Reza Moussavi; Farideh Samadi; Koorosh Ghaznavi; Homa Asgharifard; Amir-Hossein Zangiabadi; Farhad Shahram; Abdolhadi Nadji; Mahmood Akbarian; Farhad Gharibdoost; Johannes J Rasker
Journal:  Clin Rheumatol       Date:  2009-07-26       Impact factor: 2.980

5.  Brazilian urban population norms derived from the health-related quality of life SF-6D.

Authors:  Rozana Mesquita Ciconelli; Marcos Bosi Ferraz; Sérgio Kowalski; Geraldo da Rocha Castelar Pinheiro; Emilia Inoue Sato
Journal:  Qual Life Res       Date:  2015-04-18       Impact factor: 4.147

6.  WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran.

Authors:  Nasrin Moghimi; Fereydoun Davatchi; Ezat Rahimi; Afshin Saidi; Naser Rashadmanesh; Solmaz Moghimi; Hoshyar Ghafori; Peiman Zandi; Negin Ahmadi; Hamed Ghafori; Mohsen Moghimi; Marjan hajiheshmati
Journal:  Clin Rheumatol       Date:  2013-11-09       Impact factor: 2.980

7.  Prevalence and incidence of rheumatoid arthritis in South Korea.

Authors:  Yoon-Kyoung Sung; Soo-Kyung Cho; Chan-Bum Choi; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2012-12-20       Impact factor: 2.631

8.  Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample.

Authors:  Maiza Ritomy Ide; Miguel A Gonzalez-Gay; Kelly Cristina Yano; Marcelo Jun Imai; Mario Chueire de Andrade; Javier Llorca
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

Review 9.  Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review.

Authors:  Nurullah Akkoc
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

10.  Prevalence of fibromyalgia in a low socioeconomic status population.

Authors:  Ana Assumpção; Alane B Cavalcante; Cristina E Capela; Juliana F Sauer; Suellen D Chalot; Carlos A B Pereira; Amélia P Marques
Journal:  BMC Musculoskelet Disord       Date:  2009-06-08       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.